cmp (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
cmp
Cmp, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 55486 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cmp/product/ATCC
Average 99 stars, based on 55486 article reviews
Cmp, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 55486 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cmp/product/ATCC
Average 99 stars, based on 55486 article reviews
cmp - by Bioz Stars,
2026-05
99/100 stars
Images
1) Product Images from "Evaluation of the protective effect of quercetin and luteolin against ciprofloxacin- and chloramphenicol-induced oxidative stress in blood cells and their impact on the microbiological activity"
Article Title: Evaluation of the protective effect of quercetin and luteolin against ciprofloxacin- and chloramphenicol-induced oxidative stress in blood cells and their impact on the microbiological activity
Journal: Frontiers in Pharmacology
doi: 10.3389/fphar.2025.1626058
Figure Legend Snippet: Intracellular ROS production of CIP (A) and CMP (B) in MN and PMN leukocytes. Data (means ± S.D.) were expressed as percent of values in control cells of three independent experiments. *** p < 0.001 vs. control.
Techniques Used: Control
Figure Legend Snippet: Dose–response curves for Q, LT, and vitamin C on intracellular ROS produced by 16 μg/mL CIP (A) and 10 μg/mL CMP (B) in PMN human leukocytes.
Techniques Used: Produced
Figure Legend Snippet: Effect of LT and Q on SOD enzyme activity in PMN human leukocytes exposed to CIP (A) and CMP (B) . Data (means ± S.D.) are expressed as SOD units per 10 6 cells of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, statistical differences compared to control leukocytes; # p < 0.05, ## p < 0.01, ### p < 0.001, statistical differences compared to leukocytes treated with CIP or CMP.
Techniques Used: Activity Assay, Control
Figure Legend Snippet: Effect of LT and Q on CAT enzyme activity in PMN human leukocytes exposed to CIP (A) and CMP (B) . Data (means ± S.D.) are expressed as CAT units per 10 6 cells of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, statistical differences compared to control leukocytes; # p < 0.05, ## p < 0.01, ### p < 0.001, statistical differences compared to leukocytes treated with CIP or CMP.
Techniques Used: Activity Assay, Control
Figure Legend Snippet: Effect of LT and Q on protein oxidation induced by CIP (A) and CMP (B) in PMN human leukocytes. Data (means ± S.D.) are expressed as µmol chloramine T per mg protein of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, statistical differences compared to control leukocytes; # p < 0.05, ## p < 0.01, ### p < 0.001, statistical differences compared to leukocytes treated with CIP or CMP.
Techniques Used: Control
Figure Legend Snippet: Quercetin (Q) and chloramphenicol (CMP) interaction by checkerboard assay. (A) Escherichia coli clinical strain resistant to CIP. (B) Staphylococcus aureus clinical strain resistant to CIP. (C) Escherichia coli ATCC 25922. (D) Staphylococcus aureus ATCC 29213.
Techniques Used:
Figure Legend Snippet: Luteolin (LT) and chloramphenicol (CMP) interaction by checkerboard assay. (A) Escherichia coli clinical strain resistant to CIP. (B) Staphylococcus aureus clinical strain resistant to CIP. (C) Escherichia coli ATCC 25922. (D) Staphylococcus aureus ATCC 29213.
Techniques Used: